CCR7 and neoplasm: The prevalence of tumour-retained Kaede-red CCR7+ DCs was validated over a time-course in all tumour models, by flow cytometry, where CCR7+ DCs were the major Kaede-red DC cell-type up to 72 h post-photoconversion (Fig. 1f, g, Supplementary Fig. 2i).